Phase-II Trial Using Gemcitabine as Monochemotherapy in Patients with Metastasized Pancreatic Carcinoma | springermedizin.at

Springer Medizin Österreich

nach oben

European Surgery

Erschienen in:

01.12.2003 | Original Scientific Paper

Phase-II Trial Using Gemcitabine as Monochemotherapy in Patients with Metastasized Pancreatic Carcinoma

verfasst von: F. Meyer, K. Eichelmann, H. Lippert, K. Ridwelski

Erschienen in: European Surgery | Ausgabe 6/2003

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Characteristics of Patients with Patent versus Closed Left Internal Thoracic Artery Grafts before Redo Revascularization

Nächster Artikel Phase-II Trial Using Gemcitabine as Monochemotherapy in Patients with Metastasized Pancreatic Carcinoma

Titel: Phase-II Trial Using Gemcitabine as Monochemotherapy in Patients with Metastasized Pancreatic Carcinoma
verfasst von: F. Meyer
K. Eichelmann
H. Lippert
K. Ridwelski
Publikationsdatum: 01.12.2003
Verlag: Springer-Verlag
Erschienen in: European Surgery / Ausgabe 6/2003
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI: https://doi.org/10.1007/s10353-003-0044-5

Weitere Artikel der Ausgabe 6/2003

Phase-II Trial Using Gemcitabine as Monochemotherapy in Patients with Metastasized Pancreatic Carcinoma

Invited Commentary

Continuous Ambulatory Peritoneal Dialysis – Surgical Technique, Early and Late Complications

Main Topic

Characteristics of Patients with Patent versus Closed Left Internal Thoracic Artery Grafts before Redo Revascularization

Original Scientific Paper

Surgery of Arteriovenous Interposition Grafts

Main Topic

Renal Transplantation

Main Topic

OPCAB: Reducing the Perioperative Risk Avoiding Extracorporeal Circulation in CABG Surgery

Invited Commentary